The Patent Finder

Biosensors International Group, Ltd.

23 patents currently held · Updated Nov 21, 2026
27 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

11
Ending by 2030
May 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Apr 10 to 29, 2027 · next Apr 10
  • 1 fee due Aug 4, 2027
    The maintenance fee for Vascular stent with a mixed configuration of connectors (US 10,548,749) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 2 fees due Sep 3 to 24, 2027 · next Sep 3

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,414,814Temporal intraluminal stent, methods of making and using
In force
 · USPTO record
In forceUSPTO record
US 7,862,602Indirect-release electrolytic implant delivery systems
In force
 · USPTO record
In forceUSPTO record
US 10,456,508Drug delivery endovascular stent and method of use
In force
 · USPTO record
In forceUSPTO record
US 9,802,216Automated stent coating apparatus and method
In force
 · USPTO record
In forceUSPTO record
US 7,901,451Drug-delivery endovascular stent and method for treating restenosis
In force
 · USPTO record
In forceUSPTO record
US 9,511,385Automated stent coating apparatus and method
In force
 · USPTO record
In forceUSPTO record
US 8,067,055Drug-delivery endovascular stent and method of use
In force
 · USPTO record
In forceUSPTO record
US 9,579,424Drug delivery endovascular stent and method of use
In force
 · USPTO record
In forceUSPTO record
US 9,168,159Surface textured implants
In force
 · USPTO record
In forceUSPTO record
US 8,573,150Automated stent coating apparatus and method
In force
 · USPTO record
In forceUSPTO record
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
Also on record, not counted in the 23: 27 patents in force now held by others · 12 lapsed for an unpaid fee · 44 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 11 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited